0001127602-22-025157.txt : 20221108
0001127602-22-025157.hdr.sgml : 20221108
20221108184430
ACCESSION NUMBER: 0001127602-22-025157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221105
FILED AS OF DATE: 20221108
DATE AS OF CHANGE: 20221108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Derek
CENTRAL INDEX KEY: 0001917312
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 221370286
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-11-05
0000318154
AMGEN INC
AMGN
0001917312
Miller Derek
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320
1
SVP, Human Resources
Common Stock
2022-11-05
4
F
0
63
269.04
D
5973
D
63 shares issuable upon the vesting of Restricted Stock Units (RSUs) and related Dividend Equivalents (DEs) on 11/5/2022 were withheld by the Company to cover related tax withholding obligations.
These shares include the following RSUs granted under the Amgen Inc. 2009 Equity Incentive Plan: 144 RSUs which vest on 5/3/2023; 269 RSUs which will vest in installments of 132 on 5/5/2023 and 137 on 5/5/2024; 392 RSUs which will vest in two installments of 129 on 4/30/2023 and 4/30/2024 and one installment of 134 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 866 RSUs which will vest in installments of 285 on 5/2/2024, 286 on 5/2/2025, and 295 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 77 DEs granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs
and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Derek Miller
2022-11-08